Abstract:Objective To explore the effects of stosstherapy with dexamethasone on proinflam- mallory and anti-inflammatory factors in acute hepatic failure induced by D-galactosamine(D-Gal)and lipopolysaccharide in animal models and provide evidences for the mechanisms of glucocorticosteroid treatment in serious hepatic failure.Methods The male BALB/c mice were divided into three groups randomly:6 in healthy control group,2,1 in hepatic failure group and 24 in dexamethasone treated group.The mice were injected with lipopolysaccharide(LPS)10μg/kg and D-Gal 900 mg/kg intra- peritoneally to establish the hepatic failure model and dexamethasone was administrated simultaneously to the mice in treated group.The scra were collected from hearts of the mice 8 hours after injection in heahhy control group and from 6 animals 2,4,6,8 hours after injections in hepatic failure group and levels of alanine aminotransferase(ALT)and aspartate aminotransferase(AST)were tested.The reforming Knodell score was evaluated double-blindedly by hematoxylin and cosin staining anti his- topathologic assay of liver tissue.Kuppffer cells(KCs)were isolated by discontinuous density gradi- ent.Levels of interleukin(IL)10,tumor necrosing factor(TNF)-αand nuclear factor kappa B(NF-κB)in the supernatant of KCs were detected by enzyme linked immunosorbent assay(ELISA).IL-10 and TNF a mRNA of liver tissue were determined by semi-quantitative reverse transcriptase polymer ase chain reaction (RT PCR).Results Reforming Knodell scores 6,8 hours after injections in trea ted group and hepatic failure group were 7.500±1.871.10.830±1.472 and 10.500±1.049.15.670±1.633,respectively,with statistically significant difference (P<0.05).Serum ALT.AST level and TNF-αlevel in KCs supernatant in these two groups increased gradually with prolonged liver inju- ry and the level in trealed group was lower than hepatic failure group (P<0.01).TNF-αmRNA in liver tissue also increased with prolonged injury,which was significantly different (P<0.05)in these two groups 6.8 hours after injections.IL-10 level in KCs supernatant and liver tissue increased grad ually,which was much higher in treated group than that in hepatic failure group,especially 6 and 8 hours after injections (P<0.05).NF-κB activity in KCs supernatant increased 2 hours and peaked 4- 6 hours and was back tohaseline8 hours after injections.NFκB activity in these two groups was sig nificantly different 2,4 and 6 hours after injections (P<0.05).Conclusions Early stosstherapy with dexamethasone can protect liver from hepatic failure,which takes effect by inhibiting NFκB exprcs sion of KCs,down regulating TNF-αlevel in liver and circulation and keeping the balance of proin flammatory and anti inflammatory factors.

Dexamethasone pretreatment reduces isoproterenol-induced myocardial injury and the expression of TNF-α

Effects of Dexamethasone on Acute Myocardial Injury induced by Isoproterenol and T Cells in Spleen

Protective and therapeutic effects of dexpanthenol on isoproterenol‐induced cardiac damage in rats

Intervention of dexamethasone on TNF-α expression of focal cerebral injury following ischemia and reperfusion in rats

Effects Of Dexmedetomidine Pretreatment On Tnf-Alpha And Il-6, Oxidative Stress And Myocardial Apoptosis Of Rats After Myocardial Ischemia-Reperfusion Injury

Mechanisms of dexamethasone lreatment in acute hepatic failure induced by D-galactosamine combined with endotoxin in mice models

Isoimperatorin Reduces the Effective Dose of Dexamethasone in a Murine Model of Asthma by Inhibiting Mast Cell Activation.

Influence of DeXamethasone on Cytokines and Glucocorticoid Receptor mRNA with the Discrepancy of InterVening of in ALI Rats Induced by One-Hit and Two-Hit

Dexmedetomidine Attenuates Renal and Myocardial Ischemia/Reperfusion Injury in a Dose-Dependent Manner by Inhibiting Inflammatory Response.

Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Hyperlipidemic Rats by Inhibiting Inflammation, Oxidative Stress and NF-B

[Inhibitory Effect of Dexamethasone on Myeloid Differentiation Factor 88 and Tumor Necrosis Factor-Alpha Expressions in Mouse Peritoneal Macrophages].

Effect of dexmedetomidine on myocardial ischemia-reperfusion injury in rats

Dexmedetomidine Pretreatment Reduces Myocardial Ischemia And Reperfusion Injury In Rats By Altering Jak/Stat And Pi3k/Akt Levels

Dexamethasone Protects Mice against Acute Inflammatory Liver Injury by Regulating T Cell Immune Response

Dexmedetomidine Pretreatment Protects Against Myocardial Ischemia/Reperfusion Injury by Activating STAT3 Signaling

Effects of Different Dosages of Dexmeditomidine Pretreatment on Myocardial Ischemia Reperfusion Injury and Inflammation in Rats

Low-Dose Dexamethasone Alleviates Lipopolysaccharide-Induced Acute Lung Injury in Rats and Upregulates Pulmonary Glucocorticoid Receptors

The Effect of Dexmedetomidine Post-treatment on the Inflammatory Response of Astrocyte Induced by Lipopolysaccharide

Protective effects of dexmedetomidine preconditioning in rats with myocardial ischemia reperfusion injury and the effects on calcium regulatory proteins

Effects of methylprednisolone on myocardial function at early stage of resuscitation in the rats model of asphyxia

Dexamethasone attenuates lipopolysaccharide-induced liver injury by downregulating glucocorticoid-induced tumor necrosis factor receptor ligand in Kupffer cells